buthionine sulfoximine has been researched along with Cardiac Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Geršl, V; Hašková, P; Jirkovský, E; Mertlíková-Kaiserová, H; Popelová, O; Simůnek, T; Stěrba, M; Vávrová, A | 1 |
| El-Swefy, SE; Hagar, HH; Mohamed, HE | 1 |
2 other study(ies) available for buthionine sulfoximine and Cardiac Diseases
| Article | Year |
|---|---|
In vivo and in vitro assessment of the role of glutathione antioxidant system in anthracycline-induced cardiotoxicity.
Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Buthionine Sulfoximine; Cell Line; Daunorubicin; Dose-Response Relationship, Drug; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Heart; Heart Diseases; Hydrogen Peroxide; Male; Models, Animal; Oxidative Stress; Pyrrolidonecarboxylic Acid; Rabbits; Rats; Thiazolidines | 2011 |
The protective effect of glutathione administration on adriamycin-induced acute cardiac toxicity in rats.
Topics: Animals; Antibiotics, Antineoplastic; Antimetabolites; Blood Pressure; Buthionine Sulfoximine; Creatine Kinase; Doxorubicin; Glutathione; Heart Diseases; Heart Rate; Homocysteine; L-Lactate Dehydrogenase; Lipid Peroxidation; Lipoproteins; Male; Malondialdehyde; Myocardium; Rats; Rats, Wistar | 2000 |